Quantbot Technologies’s Blueprint Medicines BPMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-5,848
| Closed | -$750K | – | 1753 |
|
|
2025
Q2 | $750K | Buy |
+5,848
| New | +$607K | 0.02% | 881 |
|
|
2025
Q1 | – | Sell |
-76
| Closed | -$6.63K | – | 1486 |
|
|
2024
Q4 | $6.63K | Sell |
76
-1,088
| -93% | -$99.7K | ﹤0.01% | 1386 |
|
|
2024
Q3 | $108K | Buy |
+1,164
| New | +$116K | ﹤0.01% | 1160 |
|
|
2022
Q2 | – | Sell |
-1,500
| Closed | -$95K | – | 1721 |
|
|
2022
Q1 | $95K | Buy |
+1,500
| New | +$108K | 0.01% | 1060 |
|
|
2021
Q3 | – | Sell |
-783
| Closed | -$68K | – | 1539 |
|
|
2021
Q2 | $68K | Buy |
+783
| New | +$71.7K | 0.01% | 997 |
|
|
2020
Q4 | – | Sell |
-600
| Closed | -$55K | – | 1312 |
|
|
2020
Q3 | $55K | Sell |
600
-425
| -41% | -$32.7K | 0.01% | 837 |
|
|
2020
Q2 | $79K | Buy |
1,025
+757
| +282% | +$51.2K | 0.01% | 620 |
|
|
2020
Q1 | $15K | Sell |
268
-632
| -70% | -$40.7K | 0.01% | 632 |
|
|
2019
Q4 | $72K | Buy |
900
+400
| +80% | +$29.9K | 0.01% | 890 |
|
|
2019
Q3 | $36K | Sell |
500
-300
| -38% | -$25.9K | ﹤0.01% | 1039 |
|
|
2019
Q2 | $75K | Buy |
+800
| New | +$66K | 0.01% | 816 |
|
|
2018
Q4 | – | Sell |
-748
| Closed | -$58K | – | 1044 |
|
|
2018
Q3 | $58K | Buy |
+748
| New | +$52K | ﹤0.01% | 1017 |
|
|
2018
Q2 | – | Sell |
-334
| Closed | -$30K | – | 1209 |
|
|
2018
Q1 | $30K | Sell |
334
-1,610
| -83% | -$139K | ﹤0.01% | 1030 |
|
|
2017
Q4 | $146K | Buy |
1,944
+1,890
| +3,500% | +$133K | 0.01% | 771 |
|
|
2017
Q3 | $3K | Sell |
54
-529
| -91% | -$28.3K | ﹤0.01% | 1122 |
|
|
2017
Q2 | $29K | Sell |
583
-1,899
| -77% | -$80.6K | ﹤0.01% | 963 |
|
|
2017
Q1 | $99K | Sell |
2,482
-1,372
| -36% | -$49.1K | 0.01% | 794 |
|
|
2016
Q4 | $108K | Buy |
+3,854
| New | +$116K | 0.01% | 689 |
|
Other funds holding BPMC
IA
HNB
Quantbot Technologies's BPMC Position: Q3 2025 in Review
Quantbot Technologies sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 5,848 shares — an estimated $750K sold.
Quantbot Technologies first reported a position in BPMC in Q4 2016 and held it in 18 quarters. The position peaked at $750K in Q2 2025. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.
- Quantbot Technologies reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
- Quantbot Technologies sold 5,848 Blueprint Medicines shares in Q3 2025, an estimated $750K.
- Quantbot Technologies first reported a position in Blueprint Medicines in Q4 2016 and held it in 18 quarters.
- Quantbot Technologies's Blueprint Medicines position peaked at $750K in Q2 2025.
- 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.
Based on Quantbot Technologies's 13F filing for Q3 2025, filed 12 Nov 2025.